Calcimedica
NASDAQ: CALCLa Jolla, US · Delaware corporation · 3 known investors
Biotech
Founders & leadership
EW
Eric W. RobertsExecutive Officer, Director
DG
Daniel GeffkenExecutive Officer
AR
A. Rachel LehenyExecutive Officer, Director
KA
Kenneth A. StaudermanExecutive Officer
SH
Sudarshan HebbarExecutive Officer
EB
Eric BjerkholtDirector
FG
Frederic GuerardDirector
RN
Robert N. WilsonDirector
FM
Fred MiddletonDirector
MJ
Michael J. DunnExecutive Officer
AS
Allan ShawDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$9.1MraisedApr 2023 · 55 investors · BiotechnologyRule 506(b)
▶$9.1MraisedApr 2023 · 55 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eric W. RobertsExecutive Officer, Director
- Daniel GeffkenExecutive Officer
- A. Rachel LehenyExecutive Officer, Director
- Kenneth A. StaudermanExecutive Officer
- Sudarshan HebbarExecutive Officer
- Eric BjerkholtDirector
- Frederic GuerardDirector
- Robert N. WilsonDirector
- Fred MiddletonDirector
- Michael J. DunnExecutive Officer
- Allan ShawDirector
- Offering amount
- $9.1M
- Amount sold
- $9.1M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$55MraisedAug 2019 · 8 investors · PharmaceuticalsRule 506(b)
▶$55MraisedAug 2019 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Gerald Cagle, Ph.D.Director
- Chau KhuongDirector
- Emmett Cunningham, M.D., Ph.D.Director
- Christy Shaffer, Ph.D.Director
- Cameron Wheeler, Ph.D.Director
- Hansoo Michael KeyoungDirector
- Pamela WapnickExecutive Officer, Promoter
- Frederic GuerardExecutive Officer, Director, Promoter
- Offering amount
- $80M
- Amount sold
- $55M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$75.4MraisedJun 2018 · 16 investors · BiotechnologyRule 506(b)
▶$75.4MraisedJun 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald CagleDirector
- Chau KhoungDirector
- Christy ShafferDirector
- Cameron WheelerDirector
- Emmett CunninghamDirector
- Justin HanesDirector
- Jeffrey ClelandExecutive Officer, Director
- Offering amount
- $80.4M
- Amount sold
- $75.4M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedDec 2015 · 1 investors · BiotechnologyRule 506(b)
▶$750KraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald CagleDirector
- Christy ShafferExecutive Officer, Director
- Jeffrey ClelandExecutive Officer, Director
- Justin HanesDirector
- Offering amount
- $1M
- Amount sold
- $750K
- Proceeds to insiders
- $35K
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$1.7MraisedMar 2015 · 2 investors · BiotechnologyRule 506(b)
▶$1.7MraisedMar 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael O'RourkeExecutive Officer, Director
- Justin HanesDirector
- Gerald CagleDirector
- Jeffrey ClelandDirector
- Offering amount
- $1.7M
- Amount sold
- $1.7M
- Minimum investment
- $240K
- Proceeds to insiders
- $100K
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.